A method for synthesizing axially chiral aromatic conjugated dienes by asymmetric alfa-CH olefination reaction and its product
Through palladium-catalyzed chiral transient guiding basis control method, the problem of low yield and selectivity of the asymmetric C-H alkenylation reaction of the central axis chiral styrene is solved in the prior art. The use of cheap ligands and solvents is used to achieve It is highly efficient and selective in synthesis of axial chiral aryl conjugated dienes suitable for gram synthesis and other applications.
Patent Information
- Application Number
- CN202210799186.6
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2022-07-06
- Publication Date
- 2024-11-01
- Estimated Expiration
- 2042-07-06
AI Technical Summary
The prior art has low yield and selectivity in the asymmetric C-H alkenylation reaction of axial chiral styrene, and the sulfide-direction group used is not easy to be chemically modified, and the chiral phosphate ligand is expensive, which limits the synthetic application. .
Using palladium-catalyzed chiral transient guiding group control method, the C-H alkenyl reaction of styrene alpha alpha position is subjected to a six-metal heterocyclic intermediate, using cheap and easy-to-get L-tert-leucine and trifluoroacetic acid/DMSO as solvents to prepare axial chiral styrene.
Achieved efficient and selective synthesis of axial chiral aryl conjugated dienes, with yields up to 67-92%, ee values up to 90:10, suitable for gram synthesis and provide a wide range of chemical conversion selectivity and economic benefits.
Smart Images

Figure CN115073294B_ABST
Abstract
Description
Technical Field
[0001] The invention relates to a method for preparing axially chiral aromatic diene, in particular to a method for synthesizing axially chiral aromatic conjugated diene by asymmetric alfa-CH olefination reaction and a product thereof. Background Art
[0002] As we all know, conjugated diene structures are important components in synthetic organic chemistry and are key structural motifs in natural products and various bioactive molecules. Conjugated dienes are also often used as ligands in transition metal-catalyzed reactions (Org. Chem. Front., 2015, 2, 73–89; ACS Catal., 2017, 7, 833–847). Currently, a variety of methods for preparing conjugated diene compounds have been reported, including carbonyl olefination, olefin metathesis, Heck reaction, elimination of appropriate alkanes, and insertion coupling of alkynes. These methods have made some progress in the efficient E / Z selective synthesis of multi-substituted alkenes (Acc. Chem. Res., 2008, 41, 1474-1485). With the depletion of energy and the increasingly severe environmental problems, it is particularly urgent to develop efficient and highly selective methods for the synthesis of 1,3 diene compounds.
[0003] Axially chiral compounds are ubiquitous in natural products and pharmaceuticals and have been widely used as universal chiral ligands or catalysts in asymmetric synthesis. Unlike the well-studied axially chiral biaryl compounds, chiral styrenes exhibit chirality between substituted olefins and aromatic rings. Although this type of axially chiral compound was recognized and studied in depth by Adams et al. in the 1940s (J. Am. Chem. Soc., 1940, 62, 53–56), its flexible structure, relatively low rotation barrier, and difficulty in asymmetric synthesis have greatly reduced its attention. In recent years, axially chiral styrenes have been booming because chiral olefins can be used not only as synthons for total synthesis (Angew. Chem. Int. Ed. Engl.; 2009, 48, 5633–5637), but also as chiral catalysts or ligands in asymmetric synthesis (Angew. Chem. Int. Ed. Engl.; 2008, 47, 4482–4502). Tan Bin's group (Nat. Commun., 2017, 8, 15238) and Yan Hailong's group (J. Am. Chem. Soc., 2018, 140, 7056–7060) reported a method for synthesizing axially chiral styrene by asymmetric catalytic strategy of organic molecules. Recently, asymmetric CH functionalization strategy has also been used to construct axially chiral styrene. Shi Bingfeng's group has successively reported the strategy of synthesizing axially chiral styrene by Pd-catalyzed aromatic CH functionalization (Angew. Chem. Int. Ed., 2020, 59, 6576–6580; Chem., 2020, 6, 497–511), which provides a new technical means for the synthesis of axially chiral styrene. Wang Xisheng's group reported the synthesis of axially chiral styrene-type carboxylic acids by Pd-catalyzed asymmetric aromatic CH functionalization (Chem. Sci., 2021, 12, 3726–3732). However, there are few reports on the method of synthesizing axially chiral styrene by asymmetric alkenyl CH functionalization. In 2021, Shi Bingfeng's research group reported the synthesis of axially chiral phenyl conjugated dienes by Pd-catalyzed sulfide-directed alkenyl hydrocarbon alkenylation (J.Am.Chem.Soc., 2021, 143, 12335-12344). The reaction involved an asymmetric CH alkenylation reaction at the β position of styrene, which went through a six-membered metal heterocyclic intermediate. However, the applied sulfide directing group is not easy to chemically modify, and the chiral phosphate ligand used is expensive, which has great limitations in synthetic applications.
[0004] The inventors previously reported the synthesis of an axially chiral aromatic conjugated diene compound controlled by a chiral transient directing group under palladium catalysis. The reaction uses a simple ortho-alkenyl-benzaldehyde as a raw material, N,N-diisopropyl-protected L-tert-leucine as a ligand, acetic acid / DMSO as a mixed solvent, and undergoes a seven-membered endo-metal heterocyclic intermediate through a styrene beta-position asymmetric alkenyl CH olefination reaction to obtain an axially chiral benzaldehyde with a maximum yield of 89% and an ee value of >99 / 1 (Org. Chem. Front., 2022, 9, 2109). However, when the reaction conditions are applied to the styrene alpha-position asymmetric alkenyl CH olefination reaction, the yield and selectivity are very low.
[0005]
[0006] Here, the present invention proposes a synthesis of an axially chiral aromatic conjugated diene compound controlled by a chiral transient directing group under palladium catalysis. The reaction uses simple ortho-alkenyl-benzaldehyde as a raw material and simple L-tert-leucine as a ligand. Through the asymmetric alkenyl CH olefination reaction of styrene alpha position, it undergoes a six-membered exo-metal heterocyclic intermediate to obtain axially chiral styrene. Compared with the previous method, the present invention uses cheap and easily available L-tert-leucine as a ligand and trifluoroacetic acid / DMSO as a mixed solvent. The chiral aromatic aldehyde obtained has a wide range of chemical conversion selectivity, and the reaction conditions are mild, which is suitable for gram-scale synthesis. The axially chiral benzaldehyde obtained by this method can be oxidized to obtain axially chiral benzoic acid, which can be used as a chiral ligand for cobalt-catalyzed asymmetric CH alkylation reaction, and the er value is as high as 90:10.
[0007] Summary of the invention
[0008] The purpose of the present invention is to provide a method for synthesizing axially chiral aromatic 1,3-diene in view of the deficiencies of the prior art.
[0009] To achieve the above object, the present invention adopts the following technical scheme for synthesizing the compound represented by formula (1):
[0010]
[0011] In formula (1), R 1 C 1~4 Alkyl or C 6~10 Aryl; R 2 is an ester group, a phenyl group or an amide group; R is a methyl group or a C6 aromatic group.
[0012] Preferably, R in formula (1) 1is n-butyl, phenyl, naphthyl, 4-methyl substituted phenyl, 4-fluoro substituted phenyl, 4-methoxy substituted phenyl, 2-methyl substituted phenyl, 2-fluoro substituted phenyl, 3-methyl substituted phenyl, 3-methoxy substituted phenyl; R 2 It is n-butyl ester group, tert-butyl ester group, phenyl ester group, N,N-dimethylformamide group, phenyl group, geranyl ester group, dehydroabietyl amide group, β-sitosterol ester group; R is methyl or phenyl group.
[0013] More preferably, the chemical structure of the axially chiral aromatic 1,3-diene is one of the following:
[0014]
[0015]
[0016] The present invention uses a simple transition metal salt as a catalyst under relatively mild conditions and does not require an exogenous oxidant to prepare a 1,3-diene compound from a simple raw material, styrene. The reaction formula is as follows:
[0017]
[0018] Add transition metal salt catalyst, ligand L3, oxidant, co-oxidant, acid, organic solvent to the reaction vessel, then add o-alkenyl-benzaldehyde and alkenyl derivative to the solution in sequence. Then seal the reaction vessel under oxygen and heat to a certain temperature for stirring and reacting for a period of time. After cooling, directly apply the mixture to flash column chromatography (PE / EA), and separate the reaction solution by direct column chromatography to obtain.
[0019] The structural formula of the ligand L3 is as follows:
[0020] Preferably, the oxidant is manganese dioxide, the co-oxidant is benzoquinone, and the acid is dibenzyl phosphate.
[0021] Preferably, the molar ratio of the o-alkenyl-benzaldehyde, alkenyl derivative, transition metal salt catalyst, ligand, oxidant, co-oxidant and acid is 1:4:0.15:0.45:1.5:1:2.
[0022] Preferably, the organic solvent is one or more of acetic acid, dimethyl sulfoxide, trifluoroacetic acid, trifluoroethanol, tert-butanol, and hexafluoroisopropanol.
[0023] Preferably, the transition metal salt catalyst is a palladium salt, more preferably palladium acetate or palladium chloride.
[0024] Preferably, 5 to 10 L of organic solvent is added per mol of o-alkenyl-benzaldehyde.
[0025] Preferably, the heating reaction temperature is 25-40° C., and the reaction time is 40-48 hours.
[0026] Preferably, the post-treatment is: the reaction solution is concentrated and then loaded on a column, the residue is separated by column chromatography using 300 mesh silica gel, the eluent is a mixture of ethyl acetate and petroleum ether in a volume ratio of 1:9, the eluent containing the target compound is collected, concentrated and dried to obtain the corresponding target product.
[0027] The compounds prepared by the present invention are all brand-new compounds, which have never been reported before and belong to a brand-new synthesis method.
[0028] Compared with the prior art, the beneficial effects of the present invention are mainly reflected in:
[0029] (1) The present invention provides a method for efficiently synthesizing novel axially chiral aromatic conjugated diene compounds, and the obtained products are all completely new and have not been reported.
[0030] (2) The synthesis method of the present invention is simple to operate, has mild reaction conditions, high reaction yield and excellent enantioselectivity, reaching up to 92% and 89% ee.
[0031] (3) The synthesis method of the present invention adopts the method of synthesizing axial chiral aromatic conjugated diene by asymmetric alpha-CH olefination reaction of styrene, which is simple and effective to operate, has higher economic benefits and lower production environmental pressure.
[0032] (4) The substrate of the present invention has a wide range of applications, a high yield (67-92%), excellent enantioselectivity (up to 99% ee), a wide range of applications, and very good economic value.
[0033] (5) The synthetic raw materials of the present invention are economical and readily available, and are suitable for the efficient preparation of 1,3-diene aromatic ring compounds. They have broad application prospects and are an effective supplement to the existing preparation methods. DETAILED DESCRIPTION
[0034] The present invention is further described below in conjunction with specific embodiments, but the protection scope of the present invention is not limited thereto.
[0035] The column chromatography separation described in the following examples all uses 300 mesh silica gel for column chromatography separation, and the eluent is a mixture of ethyl acetate and petroleum ether in a volume ratio of 1:9. The eluent containing the target compound is collected, concentrated and dried to obtain the compound represented by formula (1).
[0036] Example 1: (2E,4Z)-4-(2-Formylnaphthyl-1-yl)-5-phenyl-2,4-pentadienoic acid n-butyl ester
[0037]
[0038] Palladium acetate (3.4 mg, 0.015 mmol), ligand L3 (5.9 mg, 0.045 mmol), manganese dioxide (13.1 mg, 0.15 mmol), benzoquinone (10.9 mg, 0.1 mmol), dibenzyl phosphate (48.0 mg, 0.2 mmol), trifluoroethanol (0.5 ml) and dimethyl sulfoxide (0.5 ml) were charged into a screw cap vial. Then (Z)-1-phenylvinyl-2-naphthaldehyde (25.9 mg, 0.1 mmol) and n-butyl acrylate (51.3 mg, 0.4 mmol) were added to the solution in sequence. The vial was sealed and heated to 40 °C under oxygen and stirred for 48 hours. After cooling, the mixture was directly applied to flash column chromatography (PE / EA), and the reaction solution was separated by direct column chromatography to obtain a light yellow liquid (30.2 mg, yield 78%, ee value 93%). 1 H NMR (500MHz, CDCl3) δ10.11(s,1H),8.08(d,J=8.5Hz,1H),8.01(d,J=8.5Hz,1H),7 .97–7.94(m,2H),7.91(d,J=8.5Hz,1H),7.65–7.62(m,1H),7.49–7.46(m,2H),7.1 1–7.08(m,1H),7.01(t,J=7.5Hz,2H),6.74(d,J=7.5Hz,2H),5.14(d,J=15.5Hz,1H ),4.12–4.03(m,2H),1.60–1.54(m,2H),1.37–1.29(m,2H),0.89(t,J=7.5Hz,3H); 13 C NMR (125MHz, CDCl3) δ190.66,165.78,148.23,141.50,140.30,135.55,133.49,131.32,129.84,129.48,128.78,12 8.43,128.23,128.09,127.65,127.59,126.74,125.21,121.61,120.56,63.47,29.61,18.07,12.65; HRMS(ESI):m / z forC 26 H 24 O3Na[M+Na] + :407.1618,found:407.1613; FTIR(KBr,cm -1):3442.06,3383.18,2957.01,2354.21,1689.72,1656.07,1636.45,1557.94,1541.12,1510.28,1406.54,1398.13,1033.64; Opt.Rot.[α] 20 D=-101.9 (c=0.8, CHCl3); HPLC Daicel Chiralpak IA-H column, n-hexane / i-PrOH (98 / 2), 0.5mL / min, 254nm, 15.526min (major enantiomer), 16.693min (minor enantiomer).
[0039] Example 2: Preparation of (2E,4Z)-4-(2-formylnaphthyl-1-yl)-5-phenyl-2,4-pentadienoic acid phenyl ester
[0040]
[0041] Palladium acetate (3.4 mg, 0.015 mmol), ligand L3 (5.9 mg, 0.045 mmol), manganese dioxide (13.1 mg, 0.15 mmol), benzoquinone (10.9 mg, 0.1 mmol), dibenzyl phosphate (48.0 mg, 0.2 mmol), trifluoroethanol (0.5 ml) and dimethyl sulfoxide (0.5 ml) were charged into a screw cap vial. Then (Z)-1-phenylvinyl-2-naphthaldehyde (25.9 mg, 0.1 mmol) and phenyl acrylate (59.3 mg, 0.4 mmol) were added to the solution in sequence. The vial was sealed and heated to 40 °C under oxygen and stirred for 48 hours. After cooling, the mixture was directly applied to flash column chromatography (PE / EA), and the reaction solution was separated by direct column chromatography to obtain a white liquid (37.1 mg, yield 92%, ee value 89%). 1 H NMR (500MHz, CDCl3) δ10.17(s,1H),8.14(d,J=12.5Hz,1H),8.12(d,J=6.0Hz,1 H)8.04(d,J=8.5Hz,1H),7.97(t,J=8.5Hz,2H),7.66(t,J=7.5Hz,1H),7.55(s,1 H),7.52(t,J=7.5Hz,1H),7.34(t,J=8.0Hz,2H),7.19(t,J=7.5Hz,1H),7.12(t, J=7.5Hz,1H),7.06–7.02(m,4H),6.78(d,J=8.0Hz,2H),5.32(d,J=15.5Hz,1H);13 C NMR (125MHz, CDCl3) δ190.57,164.10,150.04,149.54,142.50,139.99,135.60,133.36,131.21,129.79,129.52,1 28.95,128.54,128.39,128.37,127.75,127.67,126.88,125.14,124.76,121.71,120.44,119.50; HRMS(ESI):m / z for C 28 H 20 O3K[M+K] + :443.1044,found:443.1050; FTIR(KBr,cm -1 ):3848.60,3744.86,3624.30,3565.42,3442.06,3419.63,2357.01,1734.58,1686 .92,1656.07,1557.94,1538.32,1504.67,1403.74,1019.63,806.54; Opt.Rot.[α] 20 D=-83.8 (c=1.0, CHCl3); HPLC DaicelChiralpak IA-H column, n-hexane / i-PrOH (95 / 5), 1.0mL / min, 254nm, 12.395min (majorenantiomer), 13.416min (minor enantiomer).
[0042] Example 3: Preparation of (2E,4Z)-4-(2-formylnaphthyl-1-yl)-N,N-dimethyl 5-phenyl-2,4-dienamine
[0043]
[0044] Palladium acetate (3.4 mg, 0.015 mmol), ligand L3 (5.9 mg, 0.045 mmol), manganese dioxide (13.1 mg, 0.15 mmol), benzoquinone (10.9 mg, 0.1 mmol), dibenzyl phosphate (48.0 mg, 0.2 mmol), trifluoroethanol (0.5 ml) and dimethyl sulfoxide (0.5 ml) were charged into a screw cap vial. Then (Z)-1-phenylvinyl-2-naphthaldehyde (25.9 mg, 0.1 mmol) and N,N-dimethylacrylamide (39.7 mg, 0.4 mmol) were added to the solution in sequence. The vial was sealed and heated to 40 °C under oxygen and stirred for 48 hours. After cooling, the mixture was directly applied to flash column chromatography (PE / EA). The reaction solution was separated by direct column chromatography to obtain a light yellow liquid (31.9 mg, yield 90%, ee value 88%, mp = 54.0 °C). 1 H NMR (500MHz, CDCl3) δ10.12(s,1H),8.09(d,J=9.0Hz,1H),8.00(d,J=8.5Hz,1H),7.97(d,J=8.0Hz,1H),7.96(s,1H),7.94(d,J=9.0Hz,1H),7.63(t,J =7.5Hz,1H),7.49–7.46(m,2H),7.07(t,J=7.5Hz,1H),7.00(t,J=7.5Hz,2H ),6.73(d,J=8.0Hz,2H),5.56(d,J=15.0Hz,1H),2.92(s,3H),2.61(s,3H); 13 C NMR (125MHz, CDCl3) δ190.96,165.26,146.19,141.04,140.32,135.46,133.76,131.62,129.93,129.49,128 .61,128.42,128.05,127.72,127.54,127.52,126.67,125.51,121.46,120.08,36.03,34.71; HRMS(ESI):m / z for C 24 H 21 NO2K[M+K] + :394.1204,found:394.1201; FTIR(KBr,cm -1):3851.40,3739.25,3649.53,3629.91,3565.42,2348.60,1737.38,1684.11, 1650.47,1563.55,1541.12,1510.28,1398.13,1386.92,1028.04; Opt.Rot.[α] 20 D=-72.7 (c=1.0, CHCl3); HPLC Daicel Chiralpak OD-Hcolumn, n-hexane / i-PrOH (90 / 10), 1.0mL / min, 254nm, 16.816min (major enantiomer), 19.483min (minor enantiomer).
[0045] Example 4: 1-((1Z,3E)-1,3-diphenyl-1,3-diene-2-yl)-2-naphthaldehyde
[0046]
[0047] Palladium acetate (3.4 mg, 0.015 mmol), ligand L3 (5.9 mg, 0.045 mmol), manganese dioxide (13.1 mg, 0.15 mmol), benzoquinone (10.9 mg, 0.1 mmol), dibenzyl phosphate (48.0 mg, 0.2 mmol), trifluoroethanol (0.5 ml) and dimethyl sulfoxide (0.5 ml) were charged into a screw cap vial. Then (Z)-1-phenylvinyl-2-naphthaldehyde (25.9 mg, 0.1 mmol) and styrene (41.7 mg, 0.4 mmol) were added to the solution in sequence. The vial was sealed and heated to 40 °C under oxygen and stirred for 48 hours. After cooling, the mixture was directly applied to flash column chromatography (PE / EA). The reaction solution was separated by direct column chromatography to obtain a yellow oily liquid (25.3 mg, yield 71%, ee value 94%). 1 H NMR (500MHz, CDCl3) δ10.19(s,1H),8.11(d,J=8.5Hz,1H),8.04(d,J=8.5Hz,1H),8.01(d,J=8.5Hz,1H),7.96(d,J=8.0Hz,1H),7.62(t,J =7.5Hz,1H),7.49–7.44(m,2H),7.27–7.16(m,6H),7.20–7.16(m,1H),7.03–6.96(m,3H),6.68(d,J=7.5Hz,2H),5.79(d,J=16.0Hz,1H); 13C NMR (125MHz, CDCl3) δ191.40,142.04,135.66,135.49,134.97,134.54,133.46,133.38,131.78,130.33,129.64,1 28.25,128.01,127.80,127.56,127.48,127.38,126.89,126.69,126.49,125.72,125.50,121.45; HRMS(ESI):m / z for C 27 H 20 OK[M+K] + :399.1146,found:399.1145; FTIR(KBr,cm -1 ):3245.79,2359.81,1698.13,1650.47,1541.12,1451.40; Opt.Rot.[α] 20 D=-25.7 (c=0.16, CHCl3); HPLC Daicel Chiralpak IA-H column, n-hexane / i-PrOH (98 / 2), 1.0mL / min, 254nm, 13.965min (major enantiomer), 16.944min (minor enantiomer).
[0048] Example 5: Preparation of n-butyl (2E,4Z)-4-(2-formylnaphthyl-1-yl)-5-(4-methylphenyl)-2,4-pentadienoate
[0049]
[0050] Palladium acetate (3.4 mg, 0.015 mmol), ligand L3 (5.9 mg, 0.045 mmol), manganese dioxide (13.1 mg, 0.15 mmol), benzoquinone (10.9 mg, 0.1 mmol), dibenzyl phosphate (48.0 mg, 0.2 mmol), trifluoroethanol (0.5 ml) and dimethyl sulfoxide (0.5 ml) were charged into a screw cap vial. Then (Z)-1-(4-methylphenylvinyl)-2-naphthaldehyde (27.3 mg, 0.1 mmol) and n-butyl acrylate (51.3 mg, 0.4 mmol) were added to the solution in sequence. The vial was sealed and heated to 40 °C under oxygen and stirred for 48 hours. After cooling, the mixture was directly applied to flash column chromatography (PE / EA), and the reaction solution was separated by direct column chromatography to obtain a yellow oily liquid (32.7 mg, yield 82%, ee value 83%). 1H NMR (500MHz, CDCl3) δ10.10(s,1H),8.08(d,J=8.5Hz,1H),8.00(d,J=8.5Hz,1H),7.96( d,J=4.0Hz,1H),7.94(d,J=3.0Hz,1H),7.91(d,J=8.5Hz,1H),7.65–7.62(m,1H),7.48– 7.47(m,1H),6.82(d,J=8.0Hz,2H),6.63(d,J=8.0Hz,2H),5.11(d,J=15.5Hz,1H),4.10 –4.04(m,2H),2.16(s,3H),1.59–1.53(m,2H),1.35–1.31(m,2H),0.89(t,J=7.5Hz,3H); 13 C NMR (125MHz, CDCl3) δ190.80,165.89,148.46,141.61,140.61,138.52,135.57,130.77,130.24,129.85,129.48,128.8 3,128.40,128.38,128.14,127.62,126.69,125.23,121.58,119.93,63.41,29.62,20.17,18.07,12.65; HRMS(ESI):m / z for C 27 H 26 O3Na[M+Na] + :421.1774,found:421.1762; FTIR(KBr,cm -1 ):3259.81,2357.01,1656.07,1636.45,1400.93; Opt.Rot.[α] 20 D=-81.9 (c=0.498, CHCl3); HPLC Daicel Chiralpak IA-H column, n-hexane / i-PrOH (99 / 1), 1.0mL / min, 254nm, 21.062min (major enantiomer), 23.744min (minor enantiomer).
[0051] Example 6: Preparation of n-butyl (2E,4Z)-4-(2-formylnaphthyl-1-yl)-5-(4-fluorophenyl)-2,4-pentadienoate
[0052]
[0053] Palladium acetate (3.4 mg, 0.015 mmol), ligand L3 (5.9 mg, 0.045 mmol), manganese dioxide (13.1 mg, 0.15 mmol), benzoquinone (10.9 mg, 0.1 mmol), dibenzyl phosphate (48.0 mg, 0.2 mmol), trifluoroethanol (0.5 ml) and dimethyl sulfoxide (0.5 ml) were charged into a screw cap vial. Then (Z)-1-(4-fluorophenylvinyl)-2-naphthaldehyde (27.7 mg, 0.1 mmol) and n-butyl acrylate (51.3 mg, 0.4 mmol) were added to the solution in sequence. The vial was sealed and heated to 40 °C under oxygen and stirred for 48 hours. After cooling, the mixture was directly applied to flash column chromatography (PE / EA), and the reaction solution was separated by direct column chromatography to obtain a light yellow oily liquid (36.5 mg, yield 91%, ee value 94%). 1 H NMR (500MHz, CDCl3) δ10.10(s,1H),8.09(d,J=8.5Hz,1H),8.02(d,J=8.5Hz,1 H),7.97–7.92(m,2H),7.89(d,J=8.5Hz,1H),7.67–7.64(m,1H),7.51–7.47(m, 1H),7.44(s,1H),6.72(s,2H),6.71(d,J=1.5Hz,2H),5.14(d,J=15.5Hz,1H),4 .12–4.04(m,2H),1.59–1.54(m,2H),1.37–1.29(m,2H),0.89(t,J=7.5Hz,3H); 13 C NMR (125MHz, CDCl3) δ190.52,165.74,161.72(d,J CF =251.3Hz),148.01,139.97(d,J CF =12.5Hz),131.01(d,J CF =2.5Hz),130.59(d,J CF =7.5Hz),129.79(d,J CF =2.5Hz),129.73,129.54,128.45(d,J CF =21.3Hz),127.73,126.85,125.06,121.67,120.62,114.89,114.71,63.50,29.60,18.07,12.64; 19 F NMR(471MHz, CDCl3)δ-110.32; HRMS(ESI):m / z for C 26 H 23FO3Na[M+Na] + :425.1523,found:425.1501; FTIR(KBr,cm -1 ):3226.17,2357.01,1656.07,1636.45,1457.01,1389.72; Opt.Rot.[α] 20 D=-352.9 (c=0.12, CHCl3); HPLC Daicel Chiralpak IA-H column, n-hexane / i-PrOH (98 / 2), 1.0mL / min, 254nm, 17.686min (major enantiomer), 19.934min (minor enantiomer).
[0054] Example 7: Preparation of n-butyl (2E,4Z)-4-(2-formylnaphthyl-1-yl)-5-(4-methoxyphenyl)-2,4-pentadienoate
[0055]
[0056] Palladium acetate (3.4 mg, 0.015 mmol), ligand L3 (5.9 mg, 0.045 mmol), manganese dioxide (13.1 mg, 0.15 mmol), benzoquinone (10.9 mg, 0.1 mmol), dibenzyl phosphate (48.0 mg, 0.2 mmol), trifluoroethanol (0.5 ml) and dimethyl sulfoxide (0.5 ml) were charged into a screw cap vial. Then (Z)-1-(4-methoxyphenylvinyl)-2-naphthaldehyde (28.9 mg, 0.1 mmol) and n-butyl acrylate (51.3 mg, 0.4 mmol) were added to the solution in sequence. The vial was sealed and heated to 40 °C under oxygen and stirred for 48 hours. After cooling, the mixture was directly applied to flash column chromatography (PE / EA), and the reaction solution was separated by direct column chromatography to obtain a light yellow oily liquid (34.9 mg, yield 84%, ee value 68%). 1H NMR (500MHz, CDCl3) δ10.10(s,1H),8.09(d,J=8.5Hz,1H),8.00(d,J=8.5Hz ,1H),7.96–7.90(m,3H),7.65–7.62(m,1H),7.49–7.45(m,1H),7.42(s,1H), 6.67(d,J=9.0Hz,2H),6.54(d,J=9.0Hz,2H),5.06(s,1H),4.11–4.03(m,2H ),3.65(s,3H),1.59–1.53(m,2H),1.36–1.29(m,2H),0.89(t,J=7.5Hz,3H); 13 C NMR (125MHz, CDCl3) δ190.92,165.99,159.21,148.64,141.23,140.77,135.62,130.54,129.85,129.57,128.78,128.4 3,128.12,127.63,126.69,126.30,125.23,121.62,119.18,113.16,63.36,54.14,29.63,18.08,12.65; HRMS(ESI):m / z for C 27 H 26 O4Na[M+Na] + :437.1723,found:437.1703; FTIR(KBr,cm -1 ):3251.40,2362.62,1653.27,1633.64,1454.21; Opt.Rot.[α] 20 D=-111.3 (c=0.25, CHCl3); HPLC Daicel ChiralpakOD-H column, n-hexane / i-PrOH (98 / 2), 0.5mL / min, 254nm, 25.607min (majorenantiomer), 27.576min (minor enantiomer).
[0057] Example 8: Preparation of n-butyl (2E,4Z)-4-(2-formylnaphthyl-1-yl)-5-(2-methylphenyl)-2,4-pentadienoate
[0058]
[0059] Palladium acetate (3.4 mg, 0.015 mmol), ligand L3 (5.9 mg, 0.045 mmol), manganese dioxide (13.1 mg, 0.15 mmol), benzoquinone (10.9 mg, 0.1 mmol), dibenzyl phosphate (48.0 mg, 0.2 mmol), trifluoroethanol (0.5 ml) and dimethyl sulfoxide (0.5 ml) were charged into a screw cap vial. Then (Z)-1-(2-methylphenylvinyl)-2-naphthaldehyde (27.3 mg, 0.1 mmol) and n-butyl acrylate (51.3 mg, 0.4 mmol) were added to the solution in sequence. The vial was sealed and heated to 40 °C under oxygen and stirred for 72 hours. After cooling, the mixture was directly applied to flash column chromatography (PE / EA), and the reaction solution was separated by direct column chromatography to obtain a light yellow oily liquid (33.2 mg, yield 83%, ee value 97%). 1 H NMR(500MHz, CDCl3)δ10.10(d,J=0.5Hz,1H),8.01–7.98(m,2H),7.94–7.91(m,3H),7 .71(s,1H),7.64–7.61(m,1H),7.53–7.49(m,1H),7.09(d,J=7.5Hz,1H),6.96(t,J=7. 0Hz,1H),6.55(t,J=7.5Hz,1H),6.29(d,J=8.0Hz,1H),5.16(d,J=15.5Hz,1H),4.13–4 .04(m,2H),2.47(s,3H),1.60–1.54(m,2H),1.37–1.29(m,2H),0.89(t,J=7.5Hz,3H); 13 C NMR (125MHz, CDCl3) δ190.61,165.91,148.09,140.14,139.67,136.49,135.32,132.28,131.84,130.36,129.65,129.48,128.2 3,128.01,127.82,127.69,126.81,126.62,125.43,124.70,121.51,120.57,63.51,29.61,19.23,18.06,12.65; HRMS(ESI):m / z for C 27 H 26 O3Na[M+Na] + :421.1774, found:421.1761; FTIR(KBr,cm -1 ):3203.74,2354.21,1650.47,1628.04,1398.13; Opt.Rot.[α]20 D=-116.3 (c=0.544, CHCl3); HPLC Daicel Chiralpak IC-H column, n-hexane / i-PrOH (92 / 8), 1.0mL / min, 254nm, 14.602min (major enantiomer), 16.477min (minorenantiomer).
[0060] Example 9: Preparation of n-butyl (2E,4Z)-4-(2-formylnaphthyl-1-yl)-5-(2-fluorophenyl)-2,4-pentadienoate
[0061]
[0062] Palladium acetate (3.4 mg, 0.015 mmol), ligand L3 (5.9 mg, 0.045 mmol), manganese dioxide (13.1 mg, 0.15 mmol), benzoquinone (10.9 mg, 0.1 mmol), dibenzyl phosphate (48.0 mg, 0.2 mmol), trifluoroethanol (0.5 ml) and dimethyl sulfoxide (0.5 ml) were added to the screw cap vial. (Z)-1-(2-fluorophenylvinyl)-2-naphthaldehyde (27.7 mg, 0.4 mmol) and n-butyl acrylate (51.3 mg, 0.4 mmol) were then added to the solution in sequence. The vial was sealed and heated to 40 °C under oxygen and stirred for 72 hours. After cooling, the mixture was directly applied to flash column chromatography (PE / EA), and the reaction solution was separated by direct column chromatography to obtain a light yellow oily liquid (30.2 mg, yield 77%, ee value 99%). 1 H NMR (500MHz, CDCl3) δ10.12(s,1H),8.07(d,J=8.5Hz,1H),8.01–7.97(m,2H),7.95(d,J=8.0 Hz,1H),7.91(d,J=8.5Hz,1H),7.76(s,1H),7.66–7.63(m,1H),7.52–7.49(m,1H),7.09–7.0 5(m,1H),7.00–6.96(m,1H),6.51(t,J=7.5Hz,1H),6.16(td,J=8.0,1.5Hz,1H),5.18(d,J=1 5.5Hz,1H),4.13–4.05(m,2H),1.60–1.55(m,2H),1.37–1.30(m,2H),0.90(t,J=7.5Hz,3H); 13 C NMR(125MHz,CDCl3)δ190.49,165.62,160.08(d,J CF=251.3Hz),147.83,139.79,135.46,132.90(d,J CF =2.5Hz),132.32(d,J CF =6.3Hz),129.81,129.72,129.65,129.58,128.47,128.35,127.70,127.49(d,J CF =2.5Hz),126.84,125.16,122.97(d,J CF =3.8Hz),121.60,121.36,114.65(d,J CF =21.3Hz),63.56,29.60,18.08,12.65; 19 F NMR(471MHz, CDCl3)δ-114.98; HRMS(ESI):m / z for C 26 H 23 FO3Na[M+Na] + :425.1523,found:425.1554; FTIR(KBr,cm -1 ):3217.76,2357.01,1658.88,1636.45,1462.6,1162.62; Opt.Rot.[α] 20 D=-77.8 (c=0.512, CHCl3); HPLC Daicel Chiralpak IA-H column, n-hexane / i-PrOH (99 / 1), 1.0mL / min, 254nm, 15.198min (major enantiomer), 17.346min (minor enantiomer).
[0063] Example 10: Preparation of n-butyl (2E,4Z)-4-(2-formylnaphthyl-1-yl)-5-(3-methylphenyl)-2,4-pentadienoate
[0064]
[0065] Palladium acetate (3.4 mg, 0.015 mmol), ligand L3 (5.9 mg, 0.045 mmol), manganese dioxide (13.1 mg, 0.15 mmol), benzoquinone (10.9 mg, 0.1 mmol), dibenzyl phosphate (48.0 mg, 0.2 mmol), trifluoroethanol (0.5 ml) and dimethyl sulfoxide (0.5 ml) were charged into a screw cap vial. Then (Z)-1-(3-methylphenylvinyl)-2-naphthaldehyde (27.3 mg, 0.1 mmol) and n-butyl acrylate (51.3 mg, 0.4 mmol) were added to the solution in sequence. The vial was sealed and heated to 40 °C under oxygen and stirred for 48 hours. After cooling, the mixture was directly applied to flash column chromatography (PE / EA), and the reaction solution was separated by direct column chromatography to obtain a yellow oily liquid (31.7 mg, yield 80%, ee value 89%). 1 H NMR (500MHz, CDCl3) δ10.10(s,1H),8.08(d,J=8.5Hz,1H),8.01(d,J=8.5Hz,1H),7.97–7.94( m,2H),7.91(d,J=8.5Hz,1H),7.65–7.62(m,1H),7.49–7.46(m,1H),7.44(s,1H),6.91(d,J=7 .5Hz,1H),6.85(t,J=7.5Hz,1H),6.63(s,1H),6.43(d,J=8.0Hz,1H),5.14(d,J=15.5Hz,1H), 4.12–4.03(m,2H),2.05(s,3H),1.60–1.54(m,2H),1.37–1.29(m,2H),0.89(t,J=7.5Hz,3H); 13 CNMR(125MHz, CDCl3)δ190.74,165.85,148.33,141.75,140.51,137.09,135.53,133.43,131.11,130.08,129.88,129.48,128.9 3,128.39,128.12,127.59,127.44,126.70,125.52,125.24,121.55,120.35,63.45,29.61,20.15,18.07,12.65; HRMS(ESI):m / z for C 27 H 26 O3Na[M+Na] + :421.1774,found:421.1759; FTIR(KBr,cm -1):3320.56,2357.01,1650.47,1633.64,1395.33; Opt.Rot.[α] 20 D=-143.8 (c=0.44, CHCl3); HPLC Daicel ChiralpakIA-H column, n-hexane / i-PrOH (98 / 2), 1.0mL / min, 254nm, 12.303min (majorenantiomer), 14.067min (minor enantiomer).
[0066] Example 11: Preparation of n-butyl (2E,4Z)-4-(2-formylnaphthyl-1-yl)-5-(3-methoxyphenyl)-2,4-pentadienoate
[0067]
[0068] Palladium acetate (3.4 mg, 0.015 mmol), ligand L3 (5.9 mg, 0.045 mmol), manganese dioxide (13.1 mg, 0.15 mmol), benzoquinone (10.9 mg, 0.1 mmol), dibenzyl phosphate (48.0 mg, 0.2 mmol), trifluoroethanol (0.5 ml) and dimethyl sulfoxide (0.5 ml) were charged into a screw cap vial. Then (Z)-1-(3-methoxyphenylvinyl)-2-naphthaldehyde (28.9 mg, 0.1 mmol) and n-butyl acrylate (51.3 mg, 0.4 mmol) were added to the solution in sequence. The vial was sealed and heated to 40 °C under oxygen and stirred for 48 hours. After cooling, the mixture was directly applied to flash column chromatography (PE / EA), and the reaction solution was separated by direct column chromatography to obtain a yellow oily liquid (37.2 mg, yield 90%, ee value 87%). 1H NMR (500MHz, CDCl3) δ10.11(s,1H),8.09(d,J=8.5Hz,1H),8.00(d,J=8.5Hz,1H),7.96(d,J=9.5 Hz,1H),7.94–7.92(m,2H),7.66–7.63(m,1H),7.51–7.45(m,1H),7.45(s,1H),6.98(t,J=16.0Hz ,1H),6.65(dd,J=8.0,2.0Hz,1H),6.51(d,J=7.5Hz,1H),6.11–6.10(m,1H),5.18(d,J=15.5Hz,1 H),4.12–4.04(m,2H),3.19(s,3H),1.60–1.54(m,2H),1.37–1.30(m,2H),0.89(t,J=7.5Hz,3H); 13 C NMR (125MHz, CDCl3) δ190.61,165.76,158.25,148.11,141.34,140.38,135.51,134.70,131.49,129.95,129.58,128.51,12 8.15,127.57,126.84,125.27,122.14,121.63,120.71,115.09,112.28,63.49,53.50,29.61,18.08,12.65; HRMS(ESI):m / z forC 27 H 26 O4Na[M+Na] + :437.1723,found:437.1701; FTIR(KBr,cm -1 ):3234.58,2357.01,1650.47,1633.64,1392.52; Opt.Rot.[α] 20 D=-130.9 (c=0.498, CHCl3); HPLC DaicelChiralpak IC-H column, n-hexane / i-PrOH (90 / 10), 1.0mL / min, 254nm, 19.065min (majorenantiomer), 27.883min (minor enantiomer).
[0069] Example 12: Preparation of n-butyl (3E,5Z)-5-(2-formylnaphthyl-1-yl)-3,5-decadienoate
[0070]
[0071] Palladium acetate (3.4 mg, 0.015 mmol), ligand L3 (5.9 mg, 0.045 mmol), manganese dioxide (13.1 mg, 0.15 mmol), benzoquinone (10.9 mg, 0.1 mmol), dibenzyl phosphate (48.0 mg, 0.2 mmol), trifluoroethanol (0.5 ml) and dimethyl sulfoxide (0.5 ml) were charged into a screw cap vial. Then (Z)-1-(1-hexene)-2-naphthaldehyde (23.9 mg, 0.1 mmol) and n-butyl 1-butenoate (56.9 mg, 0.4 mmol) were added to the solution in sequence. The vial was sealed and heated to 40 °C under oxygen and stirred for 72 hours. After cooling, the mixture was directly applied to flash column chromatography (PE / EA), and the reaction solution was separated by direct column chromatography to obtain a light yellow oily liquid (23.5 mg, yield 65%, ee value 85%). 1 H NMR (500MHz, CDCl3) δ10.11(s,1H),8.05(d,J=8.5Hz,1H),7.94–7.91(m,2H),7.85(d,J= 8.5Hz,1H),7.77(d,J=15.5Hz,1H),7.65–7.62(m,1H),7.53–7.50(m,1H),6.68(t,J=7.5 Hz,1H),5.06(d,J=15.5Hz,1H),4.10–4.01(m,2H),1.79(q,J=7.5Hz,2H),1.58–1.52(m, 2H),1.34–1.28(m,4H),1.18–1.11(m,2H),0.88(t,J=7.5Hz,3H),0.72(t,J=7.5Hz,3H); 13 C NMR (125MHz, CDCl3) δ191.12,165.96,146.89,146.00,140.14,135.41,132.35,130.06,129.77,128.16,127.80, 127.52,126.29,125.37,121.14,119.45,76.20,63.36,29.61,28.94,21.26,18.06,12.67,12.63; HRMS(ESI):m / z for C 25 H 30 O3Na[M+Na] + :401.2087,found:401.2100; FTIR(KBr,cm -1 ):3226.17,2354.21,1653.27,1633.64,1538.32,1457.01; Opt.Rot.[α]20 D=-37.5 (c=0.21, CHCl3); HPLC Daicel Chiralpak OD-H column, n-hexane / i-PrOH (98 / 2), 1.0mL / min, 254nm, 6.518min (major enantiomer), 7.693min (minor enantiomer).
[0072] Example 13: Preparation of n-butyl (3E,5Z)-5-(2-formylnaphthyl-1-yl)-6-naphthyl-3,5-hexadienoate
[0073]
[0074] Palladium acetate (3.4 mg, 0.015 mmol), ligand L3 (5.9 mg, 0.045 mmol), manganese dioxide (13.1 mg, 0.15 mmol), benzoquinone (10.9 mg, 0.1 mmol), dibenzyl phosphate (48.0 mg, 0.2 mmol), trifluoroethanol (0.5 ml) and dimethyl sulfoxide (0.5 ml) were charged into a screw cap vial. (Z)-1-(2-(naphthyl-2-yl)alkenyl)-2-naphthaldehyde (30.1 mg, 0.1 mmol) and n-butyl 1-butenoate (56.9 mg, 0.4 mmol) were then added to the solution in sequence. The vial was sealed under oxygen and heated to 40 °C and stirred for 96 hours. After cooling, the mixture was directly applied to flash column chromatography (PE / EA), and the reaction solution was separated by direct column chromatography to obtain a light yellow oily liquid (35.0 mg, yield 81%, ee value 85%). 1 H NMR (500MHz, CDCl3) δ10.15 (s, 1H), 8.11 (d, J = 8.5Hz, 1H), 8.05–8.00 (m, 2H) ,7.96(t,J=8.4Hz,2H),7.65–7.61(m,2H),7.60–7.59(m,1H),7.49–7.45(m,2 H),7.39–7.33(m,4H),6.65(dd,J=8.5,2.0Hz,1H),5.20(d,J=15.5Hz,1H),4. 15–4.02(m,2H),1.62–1.55(m,2H),1.38–1.30(m,2H),0.90(t,J=7.5Hz,3H); 13C NMR (125MHz, CDCl3) δ190.68,165.83,148.29,141.59,140.40,135.57,132.09,131.91,131.52,131.12,130.00,129.97,129.70,128.48,12 8.27,127.65,127.40,127.20,126.79,126.37,126.13,125.41,125.2 3,124.75,121.63,120.51,63.48,29.62,18.08,12.66; HRMS(ESI):m / z for C 31 H 28 O3K[M+K] + :487.1670, found:487.1654; FTIR(KBr,cm -1 ):3172.90,2359.81,1656.07,1507.48,1386.92; Opt.Rot.[α] 20 D=-171.3 (c=0.592, CHCl3); HPLC Daicel Chiralpak IC-H column, n-hexane / i-PrOH (90 / 10), 1.0mL / min, 254nm, 19.763min (major enantiomer), 23.790min (minorenantiomer).
[0075] Example 14: Preparation of n-butyl (3E,5Z)-5-(2-formyl-6-methylphenyl)-6-phenyl-3,5-hexadienoate
[0076]
[0077] Palladium acetate (3.4 mg, 0.015 mmol), ligand L3 (5.9 mg, 0.045 mmol), manganese dioxide (13.1 mg, 0.15 mmol), benzoquinone (10.9 mg, 0.1 mmol), dibenzyl phosphate (48.0 mg, 0.2 mmol), trifluoroethanol (0.5 ml) and dimethyl sulfoxide (0.5 ml) were charged into a screw cap vial. Then (Z)-3-methyl-2-phenylvinylbenzaldehyde (22.3 mg, 0.1 mmol) and n-butyl 1-butenoate (56.9 mg, 0.4 mmol) were added to the solution in sequence. The vial was sealed and heated to 40 °C under oxygen and stirred for 96 hours. After cooling, the mixture was directly applied to flash column chromatography (PE / EA), and the reaction solution was separated by direct column chromatography to obtain a light yellow liquid (31.7 mg, yield 91%, ee value 95%). 1 H NMR (500MHz, CDCl3) δ9.91 (s, 1H), 7.92 (d, J = 8.0Hz, 1H), 7.79 (d, J = 16.0Hz ,1H),7.58(d,J=8.0Hz,1H),7.49(t,J=7.5Hz,1H),7.21(s,1H),7.19–7.16( m,1H),7.15–7.11(m,2H),6.85–6.83(m,2H),5.25(s,1H),4.15–4.10(m,2H ),2.14(s,3H),1.63–1.60(m,2H),1.40–1.36(m,2H),0.93(t,J=7.5Hz,3H); 13 C NMR (125MHz, CDCl3) δ9.91 (s, 1H), 7.92 (d, J = 8.0Hz, 1H), 7.79 (d, J = 16.0Hz, 1H ),7.58(d,J=8.0Hz,1H),7.49(t,J=7.5Hz,1H),7.21(s,1H),7.19–7.16(m,1H), 7.15–7.11(m,2H),6.85–6.83(m,2H),5.25(s,1H),4.15–4.10(m,2H),2.14(s,3 H),1.63–1.60(m,2H),1.40–1.36(m,2H),0.93(t,J=7.5Hz,3H); HRMS(ESI):m / z forC 24 H 26 O3Na[M+Na] + :385.1774, found:385.1753; FTIR(KBr,cm -1):3245.79,2357.01,1653.27,1633.64,1457.01,1033.64; Opt.Rot.[α] 20 D=+1.8 (c=0.498, CHCl3); HPLC Daicel Chiralpak OD-H column, n-hexane / i-PrOH (99 / 1), 1.0mL / min, 254nm, 14.244min (major enantiomer), 16.127min (minor enantiomer).
[0078] Example 15: Preparation of (2E,4Z)-4-(2-formylnaphthyl-1-yl)-5-phenyl-2,4-pentadienoic acid geranyl
[0079]
[0080] Palladium acetate (3.4 mg, 0.015 mmol), ligand L3 (5.9 mg, 0.045 mmol), manganese dioxide (13.1 mg, 0.15 mmol), benzoquinone (10.9 mg, 0.1 mmol), dibenzyl phosphate (48.0 mg, 0.2 mmol), trifluoroethanol (0.5 ml) and dimethyl sulfoxide (0.5 ml) were charged into a screw cap vial. Then (Z)-1-phenylvinyl-2-naphthaldehyde (25.9 mg, 0.1 mmol) and geranyl acrylate (83.4 mg, 0.4 mmol) were added to the solution in sequence. The vial was sealed and heated to 40 °C under oxygen and stirred for 48 hours. After cooling, the mixture was directly applied to flash column chromatography (PE / EA), and the reaction solution was separated by direct column chromatography to obtain a brown oily liquid (39.2 mg, yield 84%, ee value 88%). 1 H NMR (500MHz, CDCl3) δ10.10(s,1H),8.07(d,J=8.5Hz,1H),8.00(d,J=8.5Hz,1H),7.98–7.94(m,2 H),7.91(d,J=8.5Hz,1H),7.64–7.62(m,1H),7.49–7.46(m,2H),7.09(t,J=7.5Hz,1H),7.01(t,J =7.5Hz,2H),6.75(d,J=7.5Hz,2H),7.30–7.27(m,1H),5.15(d,J=15.5Hz,1H),5.06–5.03(m,1H) ,4.60(d,J=7.0Hz,2H),2.09–2.04(m,2H),2.02–1.99(m,2H),1.66(d,J=6.5Hz,6H),1.57(s,3H);13 C NMR (125MHz, CDCl3) δ190.64,165.71,148.33,141.66,141.52,140.29,135.55,133.50,131.34,130.80,129.83,129.46,128.79,128.43,1 28.21,128.10,127.65,127.60,126.73,125.21,122.66,121.60,120.56,116.90,60.46,38.49,25.21,24.64,16.65,15.44; HRMS(ESI):m / z for C 32 H 32 O3K[M+K] + :503.1983, found:503.1976; FTIR(KBr,cm -1 ):3273.83,2359.81,2328.97,1656.07,1633.64,1504.67,1466.62; Opt.Rot.[α] 20 D=-147.9 (c=0.276, CHCl3); HPLC Daicel Chiralpak IA-H column, n-hexane / i-PrOH (98 / 2), 1.0mL / min, 254nm, 12.494min (major enantiomer), 13.771min (minor enantiomer).
[0081] Example 16: Preparation of (2E,4Z)-4-(2-formylnaphthyl-1-yl)-5-phenyl-2,4-pentadienoic acid dehydroabietamide
[0082]
[0083] Palladium acetate (3.4 mg, 0.015 mmol), ligand L3 (5.9 mg, 0.045 mmol), manganese dioxide (13.1 mg, 0.15 mmol), benzoquinone (10.9 mg, 0.1 mmol), dibenzyl phosphate (48.0 mg, 0.2 mmol), trifluoroethanol (0.5 ml) and dimethyl sulfoxide (0.5 ml) were charged into a screw cap vial. Then (Z)-1-phenylvinyl-2-naphthaldehyde (25.9 mg, 0.1 mmol) and propylene dehydroabietylamide (135.3 mg, 0.4 mmol) were added to the solution in sequence. The vial was sealed and heated to 40 °C under oxygen and stirred for 48 hours. After cooling, the mixture was directly applied to flash column chromatography (PE / EA). The reaction solution was separated by direct column chromatography to obtain a white liquid (47.7 mg, yield 80%, ee value 86%, mp = 92.5 °C). 1 H NMR (500MHz, CDCl3) δ10.09(s,1H),8.08(d,J=8.5Hz,1H),7.99(d,J=8.5Hz,1H),7.94–7.91(m,3H),7. 62(t,J=7.5Hz,1H),7.47–7.44(m,2H),7.12(d,J=8.0Hz,1H),7.08–7.05(m,1H),7.01–6.95(m,3H),6. 85(s,1H),6.70(d,J=8.0Hz,2H),5.14(t,J=6.5Hz,1H),5.05(d,J=15.0Hz,1H),3.21–3.09(m,2H),2.8 9–2.74(m,3H),2.21(d,J=12.5Hz,1H),1.84–1.59(m,6H),1.26–1.16(m,8H),1.16(s,3H),0.88(s,3H); 13 C NMR (125MHz, CDCl3) δ190.94,164.62,146.07,145.41,144.65,140.90,140.62,135.49, 133.71,133.68,131.22,129.93,129.49,128.61,128.43,128.07,127.76,127.54,127. 51,126.78,125.83,125.56,123.04,122.90,122.83,121.62,48.81,43.94,37.08,36.4 5,36.33,34.85,32.38,28.89,28.68,24.18,22.93,17.79,17.74,17.41; HRMS(ESI):m / z for C 42 H45 NO2Na[M+Na] + :618.3343,found:618.3315; FTIR(KBr,cm -1 ):3287.85,2357.01,1656.07,1636.45,1457.01; Opt.Rot.[α] 20 D=-307.6 (c=0.054, CHCl3); HPLC Daicel Chiralpak IC-H column, n-hexane / i-PrOH (90 / 10), 1.0mL / min, 254nm, 28.443min (major enantiomer), 48.025min (minorenantiomer).
[0084] Example 17: Preparation of (2E,4Z)-4-(2-formylnaphthyl-1-yl)-5-phenyl-2,4-pentadienoic acid β-sitosterol
[0085]
[0086] Palladium acetate (3.4 mg, 0.015 mmol), ligand L3 (5.9 mg, 0.045 mmol), manganese dioxide (13.1 mg, 0.15 mmol), benzoquinone (10.9 mg, 0.1 mmol), dibenzyl phosphate (48.0 mg, 0.2 mmol), trifluoroethanol (0.5 ml) and dimethyl sulfoxide (0.5 ml) were charged into a screw cap vial. Then (Z)-1-phenylvinyl-2-naphthaldehyde (25.9 mg, 0.1 mmol) and β-sitosteryl acrylate (187.6 mg, 0.4 mmol) were added to the solution in sequence. The vial was sealed and heated to 40 °C under oxygen and stirred for 48 hours. After cooling, the mixture was directly applied to flash column chromatography (PE / EA). The reaction solution was separated by direct column chromatography to obtain a white liquid (54.7 mg, yield 75%, ee value 98%, mp = 76.8 °C). 1H NMR(500MHz,CDCl3)δ10.11(s,1H),8.08(d,J=8.5Hz,1H),8.00(d,J=8.5Hz,1H),7.96(s,1H),7.93(dd,J=10.5,7.0Hz,2H),7.65–7.62(m,1H),7.50–7.46(m,2H),7.09(d,J=14.5Hz,1H),7.01(d,J=15.5Hz,2H),6.74(d,J=7.5Hz,2H),5.36(d,J=5.0Hz,1H),5.12(d,J=15.5Hz,1H),4.66–4.59(m,1H),2.33–2.24(m,2H),2.01–1.94(m,2H),1.86–1.80(m,3H),1.48–0.79(m,36H),0.67(d,J=9.0Hz,3H); 13 C NMR(125MHz,CDCl3)δ190.70,165.08,148.15,141.42,140.36,138.51,135.56,133.52,131.35,129.84,129.48,128.77,128.43,128.20,128.06,127.64,127.59,126.73,125.25,121.70,121.61,120.98,73.22,55.65,54.99,48.98,44.81,41.27,38.68,35.93,35.54,35.12,32.91,30.82,28.12,27.21,26.71,25.04,23.26,22.04,19.98,18.80,18.24,18.01,17.75,17.23,14.35,10.96,10.82;HRMS(ESI):m / z for C 51 H 64 O3Na[M+Na] + :747.4748,found:747.4703;FTIR(KBr,cm -1 ):3251.40,2357.1,1653.27,1633.64,1451.40;Opt.Rot.[α] 20D=-111.9 (c=0.36, CHCl3); HPLC Daicel Chiralpak IC-H column, n-hexane / i-PrOH (95 / 5), 1.0mL / min, 254nm, 14.550min (major enantiomer), 16.680min (minor enantiomer).
[0087] Application Example 1. General method for preparing axial chiral carboxylic acid (CCA):
[0088]
[0089] In a dry reaction bottle, add (2E,4Z)-4-(2-formylnaphthyl-1-yl)-5-(4-fluorophenyl)-2,4-pentadienoic acid n-butyl ester (0.2mmol), t-BuOH / THF / H2O (3mL, 2:1:3) mixed solvent, cool to 0℃, add NaH2PO4 (4.8mmol, 24.0equiv), 2-methyl-2-butene (2.6mmol, 13.0equiv), NaClO2 (0.74mmol, 3.7equiv), and warm to room temperature to react until the reaction is complete. The organic solution is concentrated in vacuo to obtain an orange oil, which is dissolved in 10mL EtOAc. The organic solution is washed with HCl (2M, 10mL×2), water (10mL) and saturated brine (10mL) in sequence. The organic layer is then dried over anhydrous Na2SO4 and concentrated in vacuo to obtain a crude carboxylic acid product. The corresponding carboxylic acid product (38.9 mg, yield 93%, ee value 92%, yellow liquid) was obtained by purification by column chromatography (PE / EA). 1 H NMR(500MHz, CDCl3)δ8.18(d,J=8.7Hz,1H),7.98(d,J=8.7Hz,1H),7.95–7.81( m,3H),7.57(t,J=7.5Hz,1H),7.42(t,J=7.7Hz,1H),7.22(s,1H),6.71(dd,J=8. 8,5.6Hz,2H),6.65(t,J=8.7Hz,2H),5.07(d,J=15.5Hz,1H),4.06(t,J=6.7Hz, 2H), 1.55 (p, J = 6.8Hz, 2H), 1.32 (dd, J = 15.1, 7.6Hz, 2H), 0.87 (t, J = 7.4Hz, 3H); 13 C NMR(125MHz,CDCl3)δ170.33,166.37,161.28(d,J CF=248.6Hz),148.33,137.15,137.04,134.76,134.64,134.63,130.70(d,J CF =3.7Hz),130.06,130.00,129.68,127.71(d,J CF =7.5Hz),127.27,126.59,125.75,125.44,118.27,114.42(d,J CF =21.3Hz),63.33,29.60,18.08,12.65; FTIR(KBr,cm -1 )3448.85,2960.44,2831.32,2716.53,2359.81,2343.55,1597.12,1364.17,1068.5,776.01,556.91,454.38; Opt.Rot.[α] 20 D=-60.2 (c=0.54, CHCl3); HPLC Daicel Chiralpak IA column, n-hexane / i-PrOH (60 / 40), 1mL / min, 254nm, 7.390min (major enantiomer), 17.881min (minorenantiomer).
[0090]
[0091] In a dry reaction bottle, add (2E,4Z)-4-(2-formylnaphthyl-1-yl)-5-(2-methylphenyl)-2,4-pentadienoic acid n-butyl ester (0.2mmol), t-BuOH / THF / H2O (3mL, 2:1:3) mixed solvent, cool to 0℃, add NaH2PO4 (4.8mmol, 24.0equiv), 2-methyl-2-butene (2.6mmol, 13.0equiv), NaClO2 (0.74mmol, 3.7equiv), and warm to room temperature to react until the reaction is complete. The organic solution is concentrated in vacuo to obtain an orange oil, which is dissolved in 10mL EtOAc. The organic solution is washed with HCl (2M, 10mL×2), water (10mL) and saturated brine (10mL) in sequence. The organic layer is then dried over anhydrous Na2SO4 and concentrated in vacuo to obtain a crude carboxylic acid product. The corresponding carboxylic acid product (37.3 mg, yield 90%, ee value 96%, yellow liquid) was obtained by purification by column chromatography (PE / EA). 1H NMR(500MHz, CDCl3)δ8.07(d,J=8.7Hz,1H),7.94(d,J=15.5Hz,1H),7.92–7.85(m,3H),7.5 5(t,J=7.2Hz,1H),7.46(d,J=7.4Hz,2H),7.01(d,J=7.5Hz,1H),6.91(t,J=7.3Hz,1H),6.55 (t,J=7.6Hz,1H),6.37(d,J=7.8Hz,1H),5.12(d,J=15.5Hz,1H),4.08(t,J=6.6Hz,2H),2.3 9(s,3H),1.57(dt,J=14.7,6.9Hz,2H),1.33(dd,J=15.1,7.5Hz,2H),0.88(t,J=7.4Hz,3H); 13 CNMR (125MHz, CDCl3) δ170.70,166.45,148.29,137.12,137.04,136.07,135.51,134.46,133.36,130.35,128.99,127.39,127. 33,127.24,127.01,126.54,126.31,126.09,125.78,125.47,124.36,118.32,63.32,29.64,18.93,18.10,12.68; FTIR(KBr,cm -1 )2956.02,2925.70,2852.24,1700.81,1596.48,1366.13,1285.36,1163.94,744.50; Opt.Rot.[α] 20 D=-56.2 (c=0.47, CHCl3); HPLC Daicel Chiralpak AD-H column, n-hexane / i-PrOH (60 / 40), 1mL / min, 254nm, 4.164min (major enantiomer), 5.654min (minor enantiomer).
[0092] Application Example 2. CCA in Co III Application in the catalytic enantioselective addition of 1,4-indole to maleimide
[0093]
[0094] N-5-methyl-pyrimidinyl indole 10 (0.20 mmol, 1.0 equiv), maleimide 11 (0.4 mmol, 2 equiv), CCA (0.02 mmol, 10 mol%), [Cp*Co(MeCN)3][SbF6]2 (0.01 mmol), activated MS13X (40 mg) were added to a dried 25 mL Schlenk tube. After cooling to 0°C, t-BuOK in TFE solution (0.1 M, 240 μL, 0.024 mmol, 12 mol%), TFE (560 μL) and DCM (200 μL) were added to the mixture and stirred at 25°C for 72 hours. After the reaction was completed, the reaction mixture was purified by silica gel column chromatography (petroleum ether / ethyl acetate = 10 / 1 to 2 / 1) to obtain a white solid (45.5 mg, yield 71%, er value 74:26). 1 H NMR (500MHz, CDCl3) δ8.55(d,J=7.8Hz,1H),8.43(s,2H),7.56(d,J=7.1Hz,1H),7.31(t,J=7.0Hz,1H),7 .23(q,J=9.1,6.8Hz,1H),6.67(s,1H),4.77(s,1H),3.17–3.05(m,4H),2.97–2.84(m,1H),2.30(s,3H); 13 C NMR (125MHz, CDCl3) δ175.99,175.44,156.71,154.84,136.26,132.53,127.52,125.2 1,122.96,121.29,119.30,114.48,109.57,41.18,35.50,24.05,14.02; HRMS(ESI)for C 18 H 16 O2N4 H[M+H] + :321.1346, found: 321.1137; FTIR2925.20, 2828.58, 1699.93, 1591.69, 1365.93, 775.34; HPLC Daicel Chiralpak IA column, n-hexane / i-PrOH (80 / 20), 1.0mL / min, Daicel Chiralpak IA column,n-hexane / i-PrOH(80 / 20),1.0mL / min,254nm,17.130min(majorenantiomer),37.385min(minor enantiomer).
[0095]
[0096] N-5-methyl-pyrimidinyl indole 10 (0.20 mmol, 1.0 equiv), maleimide 11 (0.4 mmol, 2 equiv), CCA (0.02 mmol, 10 mol%), [Cp*Co(MeCN)3][SbF6]2 (0.01 mmol), activated MS13X (40 mg) were added to a dried 25 mL Schlenk tube. After cooling to 0°C, t-BuOK in TFE solution (0.1 M, 240 μL, 0.024 mmol, 12 mol%), TFE (560 μL) and DCM (200 μL) were added to the mixture and stirred at 25°C for 72 hours. After the reaction was completed, the reaction mixture was purified by silica gel column chromatography (petroleum ether / ethyl acetate = 10 / 1 to 2 / 1) to obtain a white solid (26.3 mg, yield 41%, er value 90:10). 1 H NMR (500MHz, CDCl3) δ8.55(d,J=7.8Hz,1H),8.43(s,2H),7.56(d,J=7.1Hz,1H),7.31(t,J=7.0Hz,1H),7 .23(q,J=9.1,6.8Hz,1H),6.67(s,1H),4.77(s,1H),3.17–3.05(m,4H),2.97–2.84(m,1H),2.30(s,3H); 13 C NMR (125MHz, CDCl3) δ175.99,175.44,156.71,154.84,136.26,132.53,127.52,125.2 1,122.96,121.29,119.30,114.48,109.57,41.18,35.50,24.05,14.02; HRMS(ESI)for C 18 H 16 O2N4 H[M+H] +:321.1346,found:321.1137;FTIR 2925.20,2828.58,1699.93,1591.69,1365.93,775.34;HPLC Daicel Chiralpak IA column,n-hexane / i-PrOH(80 / 20),1.0mL / min,DaicelChiralpak IA column,n-hexane / i-PrOH(80 / 20),1.0mL / min,254nm,17.130min(majorenantiomer),37.385min(minor enantiomer).
Claims
1. A method for synthesizing axially chiral aromatic conjugated dienes by asymmetric alfa-CH olefination reaction, characterized in that The method is specifically: A transition metal salt catalyst, ligand L3, oxidant, co-oxidant, acid, and organic solvent are added to a reaction container, and then o-alkenyl-benzaldehyde of formula (2) and alkenyl derivative of formula (3) are added to the solution in sequence, and then the reaction container is sealed under oxygen and heated to a certain temperature and stirred for a period of time, and after cooling, the mixture is directly applied to flash column chromatography, and the reaction solution is directly separated by column chromatography to obtain a compound represented by formula (1); wherein the acid is dibenzyl phosphate; The structural formula of the ligand L3 is as follows: In formula (1), R 1 C 1~4 Alkyl or C 6~10 Aryl; R 2 is an ester group, a phenyl group or an amide group; R is a methyl group or a C6 aromatic group.
2. The method according to claim 1, characterized in that In formula (1), R 1 is n-butyl, phenyl, naphthyl, 4-methyl substituted phenyl, 4-fluoro substituted phenyl, 4-methoxy substituted phenyl, 2-methyl substituted phenyl, 2-fluoro substituted phenyl, 3-methyl substituted phenyl, 3-methoxy substituted phenyl; R 2 It is n-butyl ester group, tert-butyl ester group, phenyl ester group, N,N-dimethylformamide group, phenyl group, geranyl ester group, dehydroabietyl amide group, β-sitosterol ester group; R is methyl or phenyl group.
3. The method according to claim 1, characterized in that The chemical structure of the compound represented by formula (1) is one of the following:
4. The method according to claim 1, characterized in that The oxidant is manganese dioxide, and the co-oxidant is benzoquinone.
5. The method according to claim 1, characterized in that The molar ratio of the o-alkenyl-benzaldehyde, alkenyl derivative, transition metal salt catalyst, ligand, oxidant, co-oxidant and acid is 1:4:0.15:0.45:1.5:1:
2.
6. The method according to claim 1, characterized in that The organic solvent is one or more of acetic acid, dimethyl sulfoxide, trifluoroacetic acid, trifluoroethanol, tert-butanol, and hexafluoroisopropanol.
7. The method according to claim 1, characterized in that Add 5 to 10 L of organic solvent for each mol of o-alkenyl-benzaldehyde.
8. The method according to claim 1, characterized in that The transition metal salt catalyst is a palladium salt.
9. The method according to claim 1, characterized in that The heating reaction temperature is 25-40° C., and the reaction time is 40-48 hours.
